Billing and Coding: Immune Globulin

This billing and coding article provides guidance for billing immune globulin consistent with LCD L35093 and emphasizes specific modifier, NOC, and documentation requirements. Key rules: use JA/JB for IV vs SC formulations of J1561/J1569; NOC drugs require a narrative in SV101-7 (drug name, total dosage/strength, administration method) and must be billed as one unit; report drug wastage with JW (or attest no wastage with JZ) for separately payable Part B single-dose drugs, documenting discarded amounts and following stated exceptions.

"Billing and coding guidance in this article applies when immune globulin use meets the reasonable and necessary coverage criteria established in LCD L35093."

Sign up to see full coverage criteria, indications, and limitations.